Læknablaðið - 15.03.2011, Síða 10

/ meðferð geðklofa
(ziprasidone HCI)
Því sjálfstraust skiptir máli
Áhrifarík stjórn á jákvæðum og
neikvæðum einkennum án þess að
hætta líkamlegri heilsu14
Heimildir: 1. Aiptekin K, et al. Efþcacy and toierability of switching to ziprasidone from olanzapine, risperidone or haloperidol:
an international, multicenter study. Int Ctin Psychopharmacol. 2009;24(5):229-38. 2. Weiden PJ, et al. Effectiveness of switching to
ziprasidone for stable but symptomatic outpatients with schizophrenia.) Clin Psychiatry. 2oo3;64(5):58o-8. 3. Kahn RS, et al.
Effectiveness of antipsychotic drugs in þrst-episode schizophrenia and schizophreniform disorder: an open randomised dinical trial.
Lancet. 2008;371:1085-97. 4. Grootens KP, et al. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder:
Results of an 8-week double-blind randomized controlled trial. Schizophr Bull. Advanced Access published June 19 2009.
Sérlyfjatexti á bls. 194